CHIP, Centre of Excellence for Health, Immunity and Infections

CHIP, Centre of Excellence for Health, Immunity and Infections CHIP produces internationally recognised research aimed at people with affected immune systems on how best to improve their health and extend life.

Today marks the launch of SHIELD, a multi-million-euro initiative aimed at preventing infections from progressing into c...
15/12/2025

Today marks the launch of SHIELD, a multi-million-euro initiative aimed at preventing infections from progressing into cancer.
On 15–16 December 2025, Denmark’s largest hospital, Rigshospitalet in Copenhagen, hosts the kick-off meeting for the new EU-wide project, "SHIELD Joint Action".
The event brings together partners and experts from clinical, public health, policy, and community sectors, with opening addresses by EU Commissioner for Health and Animal Welfare, Olivér Várhelyi, and Danish Minister of Health, Sophie Løhde.
Read the full press release here: https://t.ly/ez6Qa
For more information about SHIELD (Strategies for Health Interventions to Eliminate Infection related Cancers) Joint Action, visit https://shield.chip.dk

We are proud to have coordinated the European Testing Week campaign for more than 10 years.This week, you can find EuroT...
16/10/2025

We are proud to have coordinated the European Testing Week campaign for more than 10 years.
This week, you can find EuroTEST and European Testing Week at the EACS Conference in Paris.
Come by and visit us at our booth in the Exhibition Hall!

23/09/2025

🚀 𝐉𝐨𝐢𝐧 𝐂𝐇𝐈𝐏 𝐚𝐬 𝐚 𝐅𝐮𝐥𝐥-𝐓𝐢𝐦𝐞 𝐏𝐡𝐃 𝐒𝐭𝐮𝐝𝐞𝐧𝐭!

CHIP, a Centre of Excellence in academic research based at Rigshospitalet, is seeking motivated candidates for two full-time PhD positions starting 1 January 2026.

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 24 October 2025

We are recruiting for:
🔹𝐏𝐡𝐃 𝐒𝐭𝐮𝐝𝐞𝐧𝐭 𝐢𝐧 𝐁𝐢𝐨𝐬𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬
Learn more & apply here: https://www.regionh.dk/job/s%C3%B8g-job/Sider/Region-Hovedstaden-soeger.aspx?positionid=264400

🔹𝐏𝐡𝐃 𝐒𝐭𝐮𝐝𝐞𝐧𝐭 – 𝐓𝐫𝐚𝐢𝐧𝐞𝐝 𝐏𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧
Learn more & apply here: https://www.regionh.dk/job/s%C3%B8g-job/Sider/Region-Hovedstaden-soeger.aspx?positionid=264402

Know someone who might be interested? Please share!

🎓🎉We are proud to announce that on Wednesday, May 28th, 2025, Tomas Jensen successfully defended his PhD thesis:🧬 “Immun...
03/06/2025

🎓🎉We are proud to announce that on Wednesday, May 28th, 2025, Tomas Jensen successfully defended his PhD thesis:

🧬 “Immunovirological dynamics in patients hospitalized with COVID-19”

Please join us in congratulating Dr. Jensen on this remarkable milestone! 👏🥳

14/05/2025

PARTNER2-STUDIET VINDER VIGTIGSTE VIDEN DELT 🏆

I fredags markerede vi AIDS-Fondets 40 års jubilæum ved at uddele priser til tre personer, som har bidraget med vigtig viden, politisk tæft og kampklare kjoler. De tre priser tager udgangspunkt i tre vendepunkter i kampen mod hiv, som i løbet af de 40 år har haft betydning for mennesker, der lever med hiv, deres partnere og nære.

Prisen for Vigtigste Viden Delt gik til PARTNER2-studiet, der er det danskledede studie, som en gang for alle har slået fast, at velbehandlet hiv ikke smitter. I en del år var det almindeligt kendt blandt læger, at der nok ikke var nogen synderlig risiko for at overføre hiv, hvis man var hiv-positiv og velbehandlet.

Det var sandsynligt, at det var sådan, men det var ikke videnskabeligt bevist, så det var ikke noget, man kunne sige med sikkerhed. Det ville være en enorm videnskabelig opgave at bevise. Man skulle bevise, at noget aldrig ville kunne ske. Det var den opgave forskerne bag PARTNER2-studiet tog på sig.

Studiet har fulgt knapt 1000 par med homoseksuelle mænd i 14 europæiske lande, hvor den ene var velbehandlet hiv-positiv, og den anden ikke havde hiv. I de knapt otte år studiet varede, havde parrene analsex uden kondom næsten 77.000 gange – uden nogen blev smittet.

PARTNER2-studiet er solid forskning, som har vakt anerkendelse blandt forskningskolleger verden over. Det er formidlet, så ingen længere er i tvivl – velbehandlet hiv smitter ikke. 💯

Resultatet af PARTNER2-studiet blev offentliggjort i 2018, og det har haft kæmpe betydning for hiv-positive verden over, for deres partnere, og for det homo-miljø, hvor hiv har fyldt så meget. PARTNER2-studiet fortjener prisen Bedste Viden Delt.

Prisen blev modtaget af sygeplejerske Tina Bruun, der også er projektleder på CHIP, som er det internationale forskningssamarbejde, der står bag PARTNER2-studiet. ❤️

📸: Mio Voisin

We would like to congratulate Nadine Jaschinski for successfully defending her PhD thesis on Cardiovascular Disease Risk...
29/04/2025

We would like to congratulate Nadine Jaschinski for successfully defending her PhD thesis on Cardiovascular Disease Risk Factors, Preventive Measures, and Incidence Trends in People with HIV.

21/02/2025

𝗧𝗮𝗹𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝘀𝗲𝘅 𝗰𝗮𝗻 𝗯𝗲 𝗮𝘄𝗸𝘄𝗮𝗿𝗱, 𝗯𝘂𝘁 𝗶𝘁 𝗱𝗼𝗲𝘀𝗻'𝘁 𝗵𝗮𝘃𝗲 𝘁𝗼 𝗯𝗲!

Join our webinar on 2 April and learn how to connect with young people about awareness in a way that actually works.

We'll discuss the latest trends in communication and explore what messages resonate with today's youth.

Register: https://bit.ly/4hInxkM

20/02/2025

Want to make a REAL difference in STI prevention among MSM?

𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝟮𝟲 𝗠𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗹𝗲𝗮𝗿𝗻 𝗵𝗼𝘄.

We'll explore the power of partnerships between public health, community organizations, and healthcare providers.

This webinar, brought to you by European Centre for Disease Prevention and Control - ECDC, European AIDS Clinical Society, and CHIP, Centre of Excellence for Health, Immunity and Infections, will help you take action in your own community.



Register: https://bit.ly/4gMCfpB

Registrations for the Innovation in Tuberculosis Workshops 2025: Research Perspectives for Europe (22-23 May 2025), co-o...
20/12/2024

Registrations for the Innovation in Tuberculosis Workshops 2025: Research Perspectives for Europe (22-23 May 2025), co-organized by CHIP, WHO Regional Office for Europe, and ECDC, are now open. Interested researchers, clinicians, and epidemiologists are invited to submit their applications at https://eurotb.net/m/innovate2endtb by 14 February 2025. A limited number of scholarships is available.
European Centre for Disease Prevention and Control - ECDC
WHO Regional Office for Europe

🎉 Congratulations to Erich Tusch on successfully defending his PhD thesis 🥳 on "Causes of Death and Mortality Risk Facto...
20/12/2024

🎉 Congratulations to Erich Tusch on successfully defending his PhD thesis 🥳 on "Causes of Death and Mortality Risk Factors Among People Living with HIV: Recent Changes and Unique Risks"!

Let’s all celebrate Erich's success together! 👏

Yet another inspiring day at We are honoured to have Lene Ryom join the panellists of the Clinical Case Study Session
12/11/2024

Yet another inspiring day at
We are honoured to have Lene Ryom join the panellists of the Clinical Case Study Session

A great session on "Managing Cardiometabolic Risk in HIV: The Role of Old and New Drugs" and we are excited to have Nadi...
11/11/2024

A great session on "Managing Cardiometabolic Risk in HIV: The Role of Old and New Drugs" and we are excited to have Nadine Jaschinski represent RESPOND (International Cohort Consortium of Infectious Disease) at the panel discussion.

Adresse

Øster Allé 56
Copenhagen
2100

Åbningstider

Mandag 09:00 - 16:00
Tirsdag 09:00 - 16:00
Onsdag 09:00 - 16:00
Torsdag 09:00 - 16:00
Fredag 09:00 - 16:00

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når CHIP, Centre of Excellence for Health, Immunity and Infections sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Genveje

Del

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Type

The Mission of CHIP

CHIP (Centre of Excellence for Health, Immunity and Infections) produces internationally recognised research aimed at people with affected immune systems on how best to improve their health and extend life.

History

For the last two decades, CHIP has focused primarily on sections of the population having immune dysfunction such as people living with HIV. More recently, this has been expanded to incorporate other patient categories such as organ transplant recipients, cancer patients, patients with autoimmune disease and other groups with increased vulnerability to infectious diseases.

In 2014, CHIP was re-named as a Centre of Excellence by the Capital region of Denmark in addition to receiving a 10-year Danish National Research Foundation Centre of Excellence grant for studying Personalized Medicine of Infectious Complications of Immune Deficiency (PERSIMUNE, www.persimune.dk).